NewsRx

Search our medical news database

Florida Alliance for Patient Care and Access

Recommendation Will Turn Back 20 Years of Prostate Cancer Efforts

Published in Cancer Weekly, October 25th, 2011

2011 OCT 25 -- The Florida Alliance for Patient Care and Access (FAPCA), representing nearly 200 physicians who treat more than 250,000 patients annually across Florida, encourages men to continue following current recommendations for prostate cancer screening.

Last week, the U.S. Preventive Services Task Force (USPSTF) recommended healthy men should no longer receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening.

This panel does not include urologists or oncologists, and no new research has been cited that would call for this drastic change in prostate cancer testing recommendations since the USPSTF...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook